
Axon Partners (APG) | Financial Analysis & Statements
Axon Partners Group S.A. | Small-cap | Industrials
Axon Partners Group S.A. | Small-cap | Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2022Income Metrics
Revenue
1.9M
Gross Profit
2.0M
105.48%
Operating Income
-204.4K
-10.62%
Net Income
-256.2K
-13.31%
EPS (Diluted)
€-0.01
Balance Sheet Metrics
Total Assets
33.6M
Total Liabilities
6.7M
Shareholders Equity
26.9M
Debt to Equity
0.25
Cash Flow Metrics
Revenue & Profitability Trend
Axon Partners Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 22.6M | 19.9M | 17.7M | 13.5M | 9.4M |
Cost of Goods Sold | -291.1K | -274.3K | -314.4K | -239.5K | -482.9K |
Gross Profit | 22.9M | 20.2M | 18.0M | 13.8M | 9.9M |
Gross Margin % | 101.3% | 101.4% | 101.8% | 101.8% | 105.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 5.2M | 4.5M | 5.4M | 4.3M | 3.6M |
Other Operating Expenses | 2.1M | 1.8M | 1.3M | 850.4K | 522.7K |
Total Operating Expenses | 7.3M | 6.3M | 6.7M | 5.2M | 4.2M |
Operating Income | 6.6M | 5.7M | 5.0M | 3.6M | 2.3M |
Operating Margin % | 29.1% | 28.6% | 28.2% | 26.8% | 24.1% |
Non-Operating Items | |||||
Interest Income | 0 | 1.5K | 1.5K | 1.5K | 1.5K |
Interest Expense | 23.0K | 43.3K | 48.7K | 59.0K | 59.3K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 7.0M | 5.5M | 5.2M | 3.5M | 1.6M |
Income Tax | 1.8M | 1.6M | 1.3M | 1.2M | 813.3K |
Effective Tax Rate % | 25.3% | 28.9% | 24.4% | 34.8% | 50.0% |
Net Income | 5.2M | 3.9M | 3.9M | 2.3M | 812.2K |
Net Margin % | 23.0% | 19.5% | 22.3% | 16.9% | 8.6% |
Key Metrics | |||||
EBITDA | 7.4M | 5.9M | 5.6M | 4.1M | 2.5M |
EPS (Basic) | - | €0.80 | €0.86 | €0.63 | €0.31 |
EPS (Diluted) | - | €0.80 | €0.86 | €0.63 | €0.31 |
Basic Shares Outstanding | - | 5153931 | - | 5307435 | 5307435 |
Diluted Shares Outstanding | - | 5153931 | - | 5307435 | 5307435 |
Income Statement Trend
Axon Partners Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 9.7M | 8.0M | 9.6M | 6.3M | 3.4M |
Short-term Investments | 1.2K | 648 | - | 1.0K | 800 |
Accounts Receivable | 4.0M | 4.9M | 5.0M | 4.0M | 2.6M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 14.6M | 14.4M | 16.1M | 10.8M | 6.5M |
Non-Current Assets | |||||
Property, Plant & Equipment | 364.6K | 358.1K | 297.3K | - | - |
Goodwill | 754.2K | 812.7K | 895.3K | 1.0M | 1.1M |
Intangible Assets | 754.2K | 812.7K | 895.3K | 1.0M | 1.1M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 19.0M | 15.7M | 8.2M | 14.1M | 11.6M |
Total Assets | 33.6M | 30.1M | 24.3M | 24.9M | 18.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | - | 1.3M | 1.6M | 883.6K |
Short-term Debt | 101.7K | 244.3K | 207.0K | 717.3K | 383.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 5.2M | 5.3M | 3.5M | 4.7M | 3.0M |
Non-Current Liabilities | |||||
Long-term Debt | 0 | 80.2K | 270.8K | 1.6M | 1.9M |
Deferred Tax Liabilities | 40.9K | 39.9K | 390.3K | 0 | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 1.5M | 1.9M | 1.7M | 2.8M | 3.3M |
Total Liabilities | 6.7M | 7.2M | 5.1M | 7.5M | 6.3M |
Equity | |||||
Common Stock | 530.7K | 530.7K | 530.7K | 472.0K | 472.0K |
Retained Earnings | 5.3M | 4.1M | 4.6M | 3.3M | 1.6M |
Treasury Stock | 1.9M | 3.0M | 5.0M | 0 | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 26.9M | 22.9M | 19.2M | 17.4M | 11.8M |
Key Metrics | |||||
Total Debt | 101.7K | 324.6K | 477.8K | 2.3M | 2.2M |
Working Capital | 9.4M | 9.1M | 12.6M | 6.0M | 3.5M |
Balance Sheet Composition
Axon Partners Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 7.0M | 5.5M | 5.2M | 3.5M | 1.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 846.6K | -211.7K | -880.9K | -1.7M | 1.1M |
Operating Cash Flow | 7.0M | 4.7M | 4.2M | 1.9M | 2.8M |
Investing Activities | |||||
Capital Expenditures | -6.4K | -60.8K | 65.6K | -21.6K | -28.8K |
Acquisitions | -19.1K | 1.0K | 35.6K | -78.0K | -1.5M |
Investment Purchases | -1.6M | -2.6M | -924.6K | -663.0K | - |
Investment Sales | 522.7K | 14.7K | 1.1M | 1.0K | 841.3K |
Investing Cash Flow | -861.4K | -2.6M | -736.4K | -761.6K | -687.5K |
Financing Activities | |||||
Share Repurchases | - | 0 | -5.0M | - | - |
Dividends Paid | -3.1M | -3.2M | -3.0M | -1.7M | -3.5M |
Debt Issuance | 26.8K | 85.6K | 0 | 1.2M | 0 |
Debt Repayment | -1.5M | -441.3K | -925.5K | -1.5M | -141.7K |
Financing Cash Flow | -4.5M | -3.6M | 2.3M | 1.3M | -3.6M |
Free Cash Flow | 7.4M | 4.5M | 1.7M | 2.3M | 3.5M |
Net Change in Cash | 1.7M | -1.5M | 5.7M | 2.4M | -1.5M |
Cash Flow Trend
Axon Partners Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.61
Price to Book
7.82
Price to Sales
5.25
Profitability Ratios
Profit Margin
29.79%
Operating Margin
11.63%
Return on Equity
19.74%
Return on Assets
15.80%
Financial Health
Current Ratio
1.74
Debt to Equity
10.27
Beta
-0.24
Per Share Data
EPS (TTM)
€1.02
Book Value per Share
€1.91
Revenue per Share
€3.13
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
apg | 79.1M | 14.61 | 7.82 | 19.74% | 29.79% | 10.27 |
Llorente Y Cuenca | 102.4M | 12.22 | 2.64 | 21.44% | 7.62% | 47.74 |
Airbus SE | 155.8B | 31.13 | 6.68 | 24.11% | 7.04% | 57.69 |
Aena S.M.E., S.A | 36.7B | 12.53 | 4.39 | 27.51% | 33.43% | 87.47 |
Ferrovial SE | 35.1B | 10.52 | 5.93 | 53.86% | 35.99% | 135.11 |
International | 20.5B | 6.68 | 3.40 | 58.30% | 9.40% | 248.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.